Literature DB >> 10230857

Analgesia-producing mechanism of processed Aconiti tuber: role of dynorphin, an endogenous kappa-opioid ligand, in the rodent spinal cord.

Y Omiya1, K Goto, Y Suzuki, A Ishige, Y Komatsu.   

Abstract

The analgesia-producing mechanism of processed Aconiti tuber was examined using rodents whose nociceptive threshold was decreased by loading repeated cold stress (RCS). The antinociceptive effect of processed Aconiti tuber (0.3 g/kg, p.o.) in RCS-loaded mice was antagonized by pretreatment with a kappa-opioid antagonist, nor-binaltorphimine (10 mg/kg, s.c.), and was abolished by an intrathecal injection of anti-dynorphin antiserum (5 microg). The Aconiti tuber-induced antinociception was inhibited by both dexamethasone (0.4 mg/kg, i.p.) and a dopamine D2 antagonist, sulpiride (10 mg/kg, i.p.), in RCS-loaded mice, and it was eliminated by both an electric lesion of the hypothalamic arcuate nucleus (HARN) and a highly selective dopamine D2 antagonist, eticlopride (0.05 microg), administered into the HARN in RCS-loaded rats. These results suggest that the analgesic effect of processed Aconiti tuber was produced via the stimulation of kappa-opioid receptors by dynorphin released in the spinal cord. It was also shown that dopamine D2 receptors in the HARN were involved in the expression of the analgesic activity of processed Aconiti tuber.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10230857     DOI: 10.1254/jjp.79.295

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  6 in total

1.  Inhibitory effect of low-dose pentazocine on the development of antinociceptive tolerance to morphine.

Authors:  Shunsuke Chiba; Masakazu Hayashida; Masanobu Yoshikawa; Haihua Shu; Tomoki Nishiyama; Yoshitsugu Yamada
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

2.  Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy.

Authors:  Toru Kono; Taishi Hata; Satoshi Morita; Yoshinori Munemoto; Takanori Matsui; Hiroshi Kojima; Hiroyoshi Takemoto; Mutsumi Fukunaga; Naoki Nagata; Mitsuo Shimada; Junichi Sakamoto; Hideyuki Mishima
Journal:  Cancer Chemother Pharmacol       Date:  2013-12       Impact factor: 3.333

3.  Ignavine: a novel allosteric modulator of the μ opioid receptor.

Authors:  Katsuya Ohbuchi; Chika Miyagi; Yasuyuki Suzuki; Yasuharu Mizuhara; Keita Mizuno; Yuji Omiya; Masahiro Yamamoto; Eiji Warabi; Yuka Sudo; Akinobu Yokoyama; Kanako Miyano; Takatsugu Hirokawa; Yasuhito Uezono
Journal:  Sci Rep       Date:  2016-08-17       Impact factor: 4.379

4.  Ester Hydrolysis Differentially Reduces Aconitine-Induced Anti-hypersensitivity and Acute Neurotoxicity: Involvement of Spinal Microglial Dynorphin Expression and Implications for Aconitum Processing.

Authors:  Teng-Fei Li; Nian Gong; Yong-Xiang Wang
Journal:  Front Pharmacol       Date:  2016-10-05       Impact factor: 5.810

5.  Molecular signaling underlying bulleyaconitine A (BAA)-induced microglial expression of prodynorphin.

Authors:  Teng-Fei Li; Hai-Yun Wu; Yi-Rui Wang; Xin-Yan Li; Yong-Xiang Wang
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

6.  Mother root of Aconitum carmichaelii Debeaux exerts antinociceptive effect in Complet Freund's Adjuvant-induced mice: roles of dynorpin/kappa-opioid system and transient receptor potential vanilloid type-1 ion channel.

Authors:  Chao Wang; Danni Sun; Chunfang Liu; Chunyan Zhu; Xianghong Jing; Shuping Chen; Cuiling Liu; Kai Zhi; Tengfei Xu; Hui Wang; Junling Liu; Ying Xu; Zhiqiang Liu; Na Lin
Journal:  J Transl Med       Date:  2015-08-30       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.